Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Colorectal Neoplasms 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Ductal, Breast 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Fulvestrant 3Radiotherapy 2Carboplatin 2repotrectinib 1neratinib 1Vorinostat 1Trastuzumab 1Taxes 1Sampling Studies 1Reverse Transcriptase Polymerase Chain Reaction 1Radiotherapy, Adjuvant 1Radiation 1Positron Emission Tomography Computed Tomography 1Paclitaxel 1Mastectomy, Segmental 1Mass Spectrometry 1Magnetic Resonance Spectroscopy 1Liquid Biopsy 1Immunohistochemistry 1High-Energy Shock Waves 1Gene Expression Profiling 1Fluorescent Antibody Technique 1Drugs, Generic 1Drug Therapy 1Doxorubicin 1Docetaxel 1Cyclophosphamide 1Crizotinib 1Counseling 1Chromatography, Liquid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Lobular × Fluorescent Antibody Technique × 1 year × Clear all
NCT00898508 2025-06-25

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

City of Hope Medical Center

Completed
563 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal, Breast, Carcinoma, Lobular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡